Restorative and health-Enhancing Sleep Time (REST)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Advanced Research Projects Agency for Health (ARPA-H) seeks proposals for the Restorative and health-Enhancing Sleep Time (REST) program. This initiative aims to transform how poor sleep is measured and treated by developing objective, home-based, closed-loop technologies. The program focuses on detecting health-relevant sleep microstructures and responding in real time to improve long-term health outcomes. Solution Summaries are due August 12, 2026, at 12pm ET.
Purpose & Scope
The REST program, under ARPA-H's Proactive Health Office (PHO), seeks to establish a technical foundation for a new generation of objective, personalized sleep health technologies. It addresses the significant public health and economic burden of poor sleep.
Proposals are sought for two Technical Areas (TAs):
- TA1: Measure & Diagnose: Develop validated, in-home systems for objective sleep physiology measurement, diagnosis of poor sleep (insomnia-focused), and classification of mechanistic sleep subtypes. This includes hardware/software, clinic-to-home translation, and integration.
- TA2: Control & Treat: Develop noninvasive, closed-loop systems that use real-time physiological measurements to personalize and deliver interventions during sleep to improve sleep quality and treat insomnia. This involves real-time neuromodulation, multi-microstructure targeting, and regulatory/commercialization readiness.
Shared non-solicited program resources (Foundational Sleep Health Modeling, Research Integrator, IV&V) will also be available.
Contract Details
- Award Instrument: Other Transaction (OT) agreements.
- Period of Performance: 66 months (5.5 years), structured into three phases: Prove Core Technical Thesis (24 mos), Demonstrate Proof-of-Concept (18 mos), and Clinical Translation and Commercialization Preparation (24 mos).
Submission & Evaluation
- Solution Summary Submission Deadline: August 12, 2026, at 12pm ET. Proposers must use the provided template (Attachment A).
- Full Proposal: Invited proposers will submit written materials and an in-person pitch.
- Evaluation Criteria: Scientific and technical merit, feasibility, innovation, proposer capabilities, and relevant experience. Budget reasonableness will be assessed for full proposals.
Eligibility
- ARPA-H welcomes proposals from commercial performers, academic institutions, and non-profit organizations.
- Federally Funded Research and Development Centers (FFRDCs) and government entities are not permitted as prime or sub-performers.
- Awards will prioritize entities conducting work in the United States.
- Active SAM.gov registration and Unique Entity Identifier (UEI) are required.
Key Dates & Notes
- Proposer's Day: July 13, 2026.
- Industry cost share is encouraged, particularly in later phases (10% in Phase 2, 50% in Phase 3 for TA1).
- Out-of-scope activities include general wellness tracking, solely pharmacologic treatment, or non-personalized interventions.
- Contact:
rest@arpa-h.gov.